Report on the results in Journal Citation Reports 2023 for Medwave.

When considering Medwave as an option for publishing your papers, it is essential to know and understand the key metrics that reflect the journal's performance and influence in the scientific community. Below are the most relevant metrics and their specific values for Medwave in 2023, with respect to the results in Journal Citation Reports (JRC).

A. Journal Impact Factor (JIF)

The Journal Impact Factor (JIF) is a metric that measures the average frequency with which articles published in a journal are cited in a given year, based on articles published in the previous two years. This indicator is widely used to assess the relevance and impact of a journal within its field.

Value for Medwave in 2023: Journal Impact Factor (JIF): 1.2

A JIF of 1.2 means that, on average, Medwave articles published in 2021 and 2022 were cited 1.2 times in 2023. This value indicates that the journal Medwave is a respectable choice for the publication of research seeking a good level of visibility and citation.

B. Ranking by Journal Impact Factor

The Ranking by Journal Impact Factor classifies journals within a specific category based on their JIF. Journals are grouped into quartiles (Q1 to Q4), where Q1 represents the journals with the highest impact factors. The ranking allows comparison of the impact of different journals within the same field of study. Medwave shares the category "Medicine, General & Internal" with several world-renowned journals, such as Lancet, PloS ONE, BMJ (British Medical Journal) and Annals of Internal Medicine. These journals are widely recognized for their high quality and high impact on the medical community, and are considered among the most influential in the field of general and internal medicine.

Value for Medwave in 2023:

• Category: Medicine, General & Internal.

• Position: 150/325

• Quartile: Q2

Medwave is in the second quartile (Q2) of its category, indicating that it is above average in terms of impact within general and internal medicine. This makes the journal a solid choice for authors looking to publish in a respectable journal with a good level of visibility and recognition.

C. Cited Half-life

The Cited Half-life is a metric that indicates the median age of articles cited in a journal during a given year. Specifically, it represents the time (in years) since publication of articles that constitute half of all citations received by the journal in that year. A longer Cited Half-life suggests that the journal's articles continue to be cited for many years, indicating a lasting impact.

Value for Medwave in 2023, Cited Half-life: 3.9 years.

A Cited Half-life of 3.9 years for Medwave means that half of the citations the journal receives in a given year come from articles that were published almost 4 years ago. This suggests that articles published in Medwave have a relatively long-lasting impact and remain relevant and cited several years after publication. For authors, this is an indication that their work in Medwave may have a prolonged citation lifespan, which is especially important for research seeking sustained impact in the scientific community.

Link to view the entire JCR report for Medwave 2023

Luis Ortiz Muñoz

Deputy Editor Medwave.